Organisation/Company Universidade de Coimbra Department Divisão de Projetos e Atividades (Bolsas) Research Field Medical sciences Researcher Profile First Stage Researcher (R1) Positions Master Positions Application Deadline 13 Apr 2026 - 23:59 (Europe/Lisbon) Country Portugal Type of Contract Temporary Job Status Full-time Hours Per Week 35 Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff position within a Research Infrastructure? NoOffer Description The University of Coimbra opens a call for the assignment of a research grant, with one position(s), under the project CENTRO2030-FEDER-02360600, title ImpulseN2BD - Nose-to-brain medications for the treatment of depression: boosting translational potential .The call is governed by this Notice of Opening, the University of Coimbra Research Grant Regulations (RBI-UC), subsidiarily by the Research Grant Regulations of the Foundation for Science and Technology (RBI-FCT), by the Research Fellow Statute (EBI), by the Norms for Grant Assignment and Management within R&D Projects, by the Code of Administrative Procedure (CPA), all in their current wording, and by other applicable national and community legislation.Master's degree holders, in the scientific area of Biomedical Engineering, Pharmaceutical Sciences, Biomedical Sciences, Biotechnology or related areas, enrolled in adoctoral degree in the scientific area of Health Sciences or enrolled in a non-degree-granting course .I.II- The non-degree-granting course must be related to the type of activity covered by the grant. Non-degree-granting courses are defined as those referred to in subparagraph e) of paragraph 3 of Article 4 of Decree-Law No. 74/2006, in its current wording, provided that, under subparagraph e) of Article 3 of RBI-FCT, they are developed in association or cooperation between the higher education institution and one or more R&D units.Candidates who have already benefited from two research grant contracts with UC in the condition of being enrolled in a doctoral degree, regardless of whether each contract has reached the maximum legally permitted duration.I.IV -Eligible for grant assignment if meeting the requirements:a) Portuguese nationals or nationals of other EU Member Statesb) Nationals of third countriesc) Stateless personsd) Beneficiaries of political refugee statusII - Grant location: Faculty of Pharmacy of the University of CoimbraIII- Scientific supervision/coordination of the grant:Ana Cristina Bairrada FortunaIV - Work Plan / Goals to be achieved:The work plan aims to use 3D biomodels of the human nasal cavity and advanced neuroimaging techniques to optimize and validate the therapeutic efficacy of innovative treatments for depression.It will include the development and characterization of new therapeutic formulations, as well as the evaluation of their biodistribution when administered with different devices in 3D biomodels of the human nasal cavity.Additionally, antidepressant efficacy will be assessed in animal models of disease using neuroimaging techniques.V.I - Renewal Possibility:Possibily renewableVI - Funding and financial conditions of the grantVI.I - Monthly grant amount (paid by bank transfer at the end of each month):1309,64€VI.II - Other financial components of the grant:N.A.VI.III -In addition to the above amounts, voluntary social security (SSV) is included when the grant has a duration of six months or more, corresponding to the first level, if the candidate opts for it, as well as mandatory personal accident insurance.VI.IV - Funding:The grant(s) assigned under this call will be funded by European Regional Development Fund (FEDER), through the Centro Regional Program 2021-2027 (Centro 2030), by Portugal 2030 and by the European Union | Notice Code: Centro2030-2024-59 | Operation code: CENTRO2030-FEDER-02360600 .VI.V -Information and publicity about the funding:In all R&D activities directly or indirectly funded by the grant, namely in all communications, publications, and scientific creations, as well as theses carried out with the support provided by the grant, the acknowledgment of EU support must be expressed through the CENTRO 2030 logo, the Portugal 2030 logo, and the emblem of the European Union, in compliance with the Communication Rules of Portugal 2030.VII - Selection Methods: Evaluation of the academic record (AR) and Interview (I)VII.I - AR- In the evaluation of the academic record, the candidates' academic performance will be assessed according to the following weights and criteria:- Criterion 1 - Specific knowledge related to the work plan- Criterion 2 -Adequacy of the candidate's profile to the work plan to be developed- Criterion 3 -Absolute merit of curriculum vitaeVII.II- I – In the evaluation of the interview, candidates' performance will be assessed according to the following weights and criteria:- Criterion 1 -Motivation and interest- Criterion 2 -Knowledge and profile appropriate to the functions to be developed- Criterion 3 -Ability to express oneself and verbal fluencyVII.III-The evaluation of the criteria and the final classification will be based on a scale from 0 to 100, with scores rounded to the nearest hundredth, applying the following formulas:- AR: criterion 1 * (40%) + criterion 2 * (30%) + criterion 3 * (30%) = X- I: criterion 1 * (40%) + criterion 2 * (40%) + criterion 3 * (20%) = X- Final Classification (FC): AR * (60%) + I * (40%) = XVII.IV -All candidates who meet the admission requirements are subject to the academic record evaluation, carried out according to the criteria and weights defined in VII.I.VII.V -Candidates who score below 50 in any selection method will be excluded, and subsequent methods, if any, will not apply to them. Candidates who are duly notified but fail to attend the interview (if applicable) or withdraw at any stage will also be excluded.VII.VI- All candidates who score above 50 in the AR will proceed to the next method, i.e., the interview.VII.VII -Tie-breaking criteria: In the event of a tie in the rankings, candidates will be ordered in descending order as follows:#J-18808-Ljbffr